about
Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics.Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapyA solid-phase platform for combinatorial and scarless multipart gene assembly.Wnt3a protein reduces growth factor-driven expansion of human hematopoietic stem and progenitor cells in serum-free cultures.Biomedical Applications of Self-Assembling Peptides.Gene based therapies for kidney regeneration.Targeted decationized polyplexes for siRNA delivery.Targeted decationized polyplexes for cell specific gene delivery.Effects of antigen-expressing immunostimulatory liposomes on chemotaxis and maturation of dendritic cells in vitro and in human skin explants.Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells.Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination.Optimization of the recombinant production and purification of a self-assembling peptide in Escherichia coli.Decationized polyplexes for gene delivery.Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes.Strategies for the Activation and Release of the Membranolytic Peptide Melittin from Liposomes Using Endosomal pH as a Trigger.Quantitative analysis of receptor-mediated uptake and pro-apoptotic activity of mistletoe lectin-1 by high content imaging.Critical evaluation of quantification methods for oligonucleotides formulated in lipid nanoparticles.Liposome functionalization with copper-free "click chemistry".Nanogels for intracellular delivery of biotherapeutics.Making individualized drugs a reality.mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting CellsModular core-shell polymeric nanoparticles mimicking viral structures for vaccinationpH-Induced Transformation of Biodegradable Multilamellar Nanovectors for Enhanced Tumor PenetrationPost-PEGylated and crosslinked polymeric ssRNA nanocomplexes as adjuvants targeting lymph nodes with increased cytolytic T cell inducing propertiesLiposome-targeted recombinant human acid sphingomyelinase: Production, formulation, and in vitro evaluationLight-Triggered Cellular Delivery of OligonucleotidesDelivery Aspects of CRISPR/Cas for in Vivo Genome EditingHemocompatibility assessment of two siRNA nanocarrier formulationsErratum: Making individualized drugs a realityCoiled coil interactions for the targeting of liposomes for nucleic acid deliveryCationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responsesThermosensitive liposomes for triggered release of cytotoxic proteinsAcute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linkerInducible Fibril Formation of Silk-Elastin DiblocksNature of Amorphous Hydrophilic Block Affects Self-Assembly of an Artificial Viral Coat PolypeptideRGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells
P50
Q30620201-B3038B17-9AA0-41F2-8910-116D96DE062AQ34626943-6135BDDF-1D71-439C-B998-6268F05DCF75Q34710204-25B4059B-7027-4269-A05B-F94F3379CA11Q35586490-90D209D9-FC4D-46DF-A78A-638C5C2D7146Q38608861-2DB61597-A8D5-4B47-8912-41C1E6B313C8Q38907936-7881A0A2-2B02-4533-836A-66C0B353F20CQ38941521-2B0089A1-AD1F-4A2F-85B2-97B03615E66DQ39013551-660A1653-9735-416A-9E20-F3412FCD9CBCQ39090799-37573E7E-E065-46E5-95EA-14273EC76A55Q41768027-21DF98C8-5FA9-47B7-B3DA-05AAB89A8775Q42261896-8B3931B1-4FC2-4D42-88D2-60C2F084D672Q43124275-38F720CC-6446-45FA-99BA-F8CF4B3D6C69Q45870434-11D33BD0-ABC0-4355-8292-FD0490A8E62AQ47718581-A78E5FBA-F4C9-4E56-82B2-933114D4BBFCQ48125775-B6A5A1BF-7658-40DC-8B2C-3171E61B7972Q49587149-DB88E9EF-0E8C-488B-A87B-1B18CD590BD7Q49596082-439834B1-AF85-477E-8D6B-46D12CD5A226Q51014166-1520F05E-551F-4702-B8F0-743078B4642AQ51236342-D4C7AFCF-4BB7-46C4-9BEB-139F70D3CAD2Q53759243-EE5FA5C0-C21A-4DFD-B121-52A6038836ABQ57044191-79B3AF23-AA67-4133-A5F1-9664A9B75A55Q59351056-FCDFB572-48A9-4FED-ABE6-0FFC0A2D1E10Q59809613-39106373-7405-4DE4-AA63-B2BCDFB711D6Q60506903-B0D03792-7E22-4D77-9C78-0D50B733121BQ64040195-89747DF3-1C70-4ECD-AF0F-CFBEC1273F18Q64121037-3CAC57A5-B7B0-4DAF-AAB0-042E16EDCF44Q64386928-118F7080-5401-48DE-BCB5-1C67B2F151C8Q87909133-3FA7E1E8-DF3F-43DF-A303-3E9047A71431Q88718467-4355B8E9-B308-4DDF-8922-925B7D7FB1F8Q89176480-394BC0D3-35BF-4B8D-B963-C30D52DE8FE3Q91042995-88850B06-40CE-4C36-916C-06EE003B4DA1Q91484494-D0C41168-F807-4C77-8274-B7D73E10D5D4Q92291032-CE74083C-4AFD-41BE-A1FE-285FFC2A4E8EQ92574102-A3473945-CCE6-4E43-BA64-35FF204F46EAQ92656697-B77B9952-03CE-423B-AA33-460A2DFD6B47Q93017551-6731097A-E18F-46A5-9D75-05664172BD37
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Enrico Mastrobattista
@en
Enrico Mastrobattista
@nl
type
label
Enrico Mastrobattista
@en
Enrico Mastrobattista
@nl
prefLabel
Enrico Mastrobattista
@en
Enrico Mastrobattista
@nl
P31
P496
0000-0002-6745-2015